{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:07:57Z","timestamp":1790446077169,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016264","name":"Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL110952"],"award-info":[{"award-number":["HL110952"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.neubiorev.2022.104870","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T12:08:32Z","timestamp":1663070912000},"page":"104870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome"],"prefix":"10.1016","volume":"142","author":[{"given":"Ozge","family":"Oztan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Zyga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.J.","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2022.104870_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2018.05.011","article-title":"Cognitive deficits in the Snord116 deletion mouse model for Prader-Willi syndrome","volume":"165","author":"Adhikari","year":"2019","journal-title":"Neurobiol. Learn Mem."},{"key":"10.1016\/j.neubiorev.2022.104870_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/1362361314524641","article-title":"Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study","volume":"19","author":"Adler","year":"2015","journal-title":"Autism"},{"key":"10.1016\/j.neubiorev.2022.104870_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.yhbeh.2011.10.007","article-title":"The regulation of social recognition, social communication and aggression: vasopressin in the social behavior neural network","volume":"61","author":"Albers","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neubiorev.2022.104870_bib4","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0910249107","article-title":"Promoting social behavior with oxytocin in high-functioning autism spectrum disorders","volume":"107","author":"Andari","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2022.104870_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nbd.2018.09.017","article-title":"Inactivation of Magel2 suppresses oxytocin neurons through synaptic excitation-inhibition imbalance","volume":"121","author":"Ates","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104870_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1615\/CritRevNeurobiol.v10.i1.60","article-title":"Vasopressin and oxytocin receptors in the central nervous system","volume":"10","author":"Barberis","year":"1996","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fnins.2015.00335","article-title":"Oxytocin and vasopressin: linking pituitary neuropeptides and their receptors to social neurocircuits","volume":"9","author":"Baribeau","year":"2015","journal-title":"Front Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104870_bib8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2008.04.009","article-title":"Oxytocin shapes the neural circuitry of trust and trust adaptation in humans","volume":"58","author":"Baumgartner","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104870_bib9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.npp.1300360","article-title":"Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice","volume":"29","author":"Bielsky","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2022.104870_bib10","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/hmg\/ddm225","article-title":"Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome","volume":"16","author":"Bischof","year":"2007","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.neubiorev.2022.104870_bib11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ajmg.a.31606","article-title":"Whole genome microarray analysis of gene expression in Prader\u2013Willi syndrome","volume":"143","author":"Bittel","year":"2007","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.neubiorev.2022.104870_bib12","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1093\/hmg\/8.13.2497","article-title":"The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region","volume":"8","author":"Boccaccio","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144450","article-title":"Correction of vasopressin deficit in the lateral septum ameliorates social deficits of mouse autism model","volume":"131","author":"Borie","year":"2021","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.neubiorev.2022.104870_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.6153132","article-title":"Synthesis, transport, and release of posterior pituitary hormones","volume":"207","author":"Brownstein","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104870_bib15","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1073\/pnas.1518825113","article-title":"Vasopressin increases human risky cooperative behavior","volume":"113","author":"Brunnlieb","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2022.104870_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng0495-395","article-title":"Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15","volume":"9","author":"Buiting","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/edrv.22.6.0447","article-title":"Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH","volume":"22","author":"Burman","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neubiorev.2022.104870_bib18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1172\/JCI88648","article-title":"Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome","volume":"127","author":"Burnett","year":"2017","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.neubiorev.2022.104870_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajmg.1320350306","article-title":"Prader-Willi syndrome: current understanding of cause and diagnosis","volume":"35","author":"Butler","year":"1990","journal-title":"Am. J. Med Genet"},{"key":"10.1016\/j.neubiorev.2022.104870_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/pcn.12627","article-title":"Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder","volume":"72","author":"Cai","year":"2018","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104870_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0079-6123(08)00427-5","article-title":"Oxytocin, vasopressin and sociality","volume":"170","author":"Carter","year":"2008","journal-title":"Prog. brain Res."},{"key":"10.1016\/j.neubiorev.2022.104870_bib22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jmg.34.11.917","article-title":"Prader-Willi syndrome","volume":"34","author":"Cassidy","year":"1997","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet. Med."},{"key":"10.1016\/j.neubiorev.2022.104870_bib24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0306-4522(88)90078-4","article-title":"The neurophysin-containing innervation of the forebrain of the mouse","volume":"24","author":"Castel","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104870_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138576","article-title":"Loss of MAGEL2 in Prader-Willi syndrome leads to decreased secretory granule and neuropeptide production","volume":"5","author":"Chen","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.neubiorev.2022.104870_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12994","article-title":"Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome","volume":"33","author":"Correa-da-Silva","year":"2021","journal-title":"J. Neuroendocr."},{"key":"10.1016\/j.neubiorev.2022.104870_bib27","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/cen.14387","article-title":"Oxytocin in young children with Prader-Willi syndrome: results of a randomized, double-blind, placebo-controlled, crossover trial investigating 3 months of oxytocin","volume":"94","author":"Damen","year":"2021","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13023-019-1221-3","article-title":"Face processing and exploration of social signals in Prader-Willi syndrome: a genetic signature","volume":"14","author":"Debladis","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neubiorev.2022.104870_bib29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.neubiorev.2019.09.034","article-title":"Circuits for social learning: a unified model and application to Autism Spectrum Disorder","volume":"107","author":"DeMayo","year":"2019","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neubiorev.2022.104870_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000313377","article-title":"Endocrine disorders in children with Prader-Willi syndrome--data from 142 children of the French database","volume":"74","author":"Diene","year":"2010","journal-title":"Horm. Res Paediatr."},{"key":"10.1016\/j.neubiorev.2022.104870_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11920-007-0086-7","article-title":"Autistic-like symptomatology in Prader-Willi syndrome: a review of recent findings","volume":"9","author":"Dimitropoulos","year":"2007","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neubiorev.2022.104870_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10803-012-1547-3","article-title":"Social responsiveness and competence in Prader-Willi syndrome: direct comparison to autism spectrum disorder","volume":"43","author":"Dimitropoulos","year":"2013","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.neubiorev.2022.104870_bib33","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1007\/s10803-019-04152-4","article-title":"Early social cognitive ability in preschoolers with prader-willi syndrome and autism spectrum disorder","volume":"49","author":"Dimitropoulos","year":"2019","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.neubiorev.2022.104870_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001709","article-title":"SnoRNA Snord116 (Pwcr1\/MBII-85) deletion causes growth deficiency and hyperphagia in mice","volume":"3","author":"Ding","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104870_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ng1096-163","article-title":"Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene","volume":"14","author":"Dittrich","year":"1996","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neubiorev.2022.104870_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/adc.70.1.58","article-title":"The Prader-Willi syndrome","volume":"70","author":"Donaldson","year":"1994","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.neubiorev.2022.104870_bib37","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1126\/science.1158668","article-title":"Oxytocin, vasopressin, and the neurogenetics of sociality","volume":"322","author":"Donaldson","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104870_bib38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.17-02-00563.1997","article-title":"Cellular localization of the prohormone convertases in the hypothalamic paraventricular and supraoptic nuclei: selective regulation of PC1 in corticotrophin-releasing hormone parvocellular neurons mediated by glucocorticoids","volume":"17","author":"Dong","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104870_bib39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF00273644","article-title":"Similar molecular deletions on chromosome 15q11.2 are encountered in both the Prader-Willi and Angelman syndromes","volume":"80","author":"Donlon","year":"1988","journal-title":"Hum. Genet"},{"key":"10.1016\/j.neubiorev.2022.104870_bib40","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/sim.5728","article-title":"A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies","volume":"32","author":"Doros","year":"2013","journal-title":"Stat. Med"},{"key":"10.1016\/j.neubiorev.2022.104870_bib41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s11689-017-9200-2","article-title":"Diagnoses and characteristics of autism spectrum disorders in children with Prader-Willi syndrome","volume":"9","author":"Dykens","year":"2017","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neubiorev.2022.104870_bib42","first-page":"3","article-title":"Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome","author":"Dykens","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.neubiorev.2022.104870_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223162","article-title":"Profiles and trajectories of impaired social cognition in people with Prader-Willi syndrome","volume":"14","author":"Dykens","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104870_bib44","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/s41436-021-01185-y","article-title":"SNORD116 and growth hormone therapy impact IGFBP7 in Prader\u2013Willi syndrome","volume":"23","author":"Eddiry","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.neubiorev.2022.104870_bib45","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/ajmg.a.36653","article-title":"A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome","volume":"164","author":"Einfeld","year":"2014","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.neubiorev.2022.104870_bib46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/77040","article-title":"Social amnesia in mice lacking the oxytocin gene","volume":"25","author":"Ferguson","year":"2000","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neubiorev.2022.104870_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neuropsychologia.2009.09.003","article-title":"The effect of intranasal administration of oxytocin on fear recognition","volume":"48","author":"Fischer-Shofty","year":"2010","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.neubiorev.2022.104870_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41582-021-00602-9","article-title":"Refining oxytocin therapy for autism: context is key","volume":"18","author":"Ford","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib49","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/gbb.12378","article-title":"Magel2 knockout mice manifest altered social phenotypes and a deficit in preference for social novelty","volume":"16","author":"Fountain","year":"2017","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neubiorev.2022.104870_bib50","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1210\/me.2008-0010","article-title":"Nescient helix-loop-helix 2 interacts with signal transducer and activator of transcription 3 to regulate transcription of prohormone convertase 1\/3","volume":"22","author":"Fox","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.brainres.2014.01.021","article-title":"Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders","volume":"1580","author":"Francis","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104870_bib52","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1210\/jcem.83.2.4542","article-title":"Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: indications for a processing defect","volume":"83","author":"Gabre\u00ebls","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neubiorev.2022.104870_bib53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neubiorev.2015.10.003","article-title":"Prader-Willi syndrome: from genetics to behaviour, with special focus on appetite treatments","volume":"59","author":"Griggs","year":"2015","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neubiorev.2022.104870_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.biopsych.2007.06.026","article-title":"Oxytocin increases gaze to the eye region of human faces","volume":"63","author":"Guastella","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104870_bib55","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.biopsych.2008.02.008","article-title":"Oxytocin enhances the encoding of positive social memories in humans","volume":"64","author":"Guastella","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104870_bib56","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.biopsych.2010.03.014","article-title":"Intranasal arginine vasopressin enhances the encoding of happy and angry faces in humans","volume":"67","author":"Guastella","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104870_bib57","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.psyneuen.2011.07.020","article-title":"Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome","volume":"37","author":"Hall","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2022.104870_bib58","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0006-3223(03)00465-7","article-title":"Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress","volume":"54","author":"Heinrichs","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104870_bib59","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jpsychires.2020.11.006","article-title":"Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi Syndrome: a randomized controlled pilot trial","volume":"137","author":"Hollander","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2022.104870_bib60","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1097-4652(199711)173:2<237::AID-JCP28>3.0.CO;2-B","article-title":"Structure and function of the human chromosome 15 imprinting center","volume":"173","author":"Horsthemke","year":"1997","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib61","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1096-6374(03)00077-7","article-title":"Peptides associated with hyperphagia in adults with Prader\u2013Willi syndrome before and during GH treatment","volume":"13","author":"H\u00f6ybye","year":"2003","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.neubiorev.2022.104870_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature05526","article-title":"CD38 is critical for social behaviour by regulating oxytocin secretion","volume":"446","author":"Jin","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104870_bib63","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ajmg.a.37488","article-title":"Elevated plasma oxytocin levels in children with Prader\u2013Willi syndrome compared with healthy unrelated siblings","volume":"170","author":"Johnson","year":"2016","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.neubiorev.2022.104870_bib64","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neubiorev.2017.01.034","article-title":"Oxytocin and vasopressin neural networks: Implications for social behavioral diversity and translational neuroscience","volume":"76","author":"Johnson","year":"2017","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neubiorev.2022.104870_bib65","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/hmg\/8.5.783","article-title":"A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region","volume":"8","author":"Jong","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib66","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000124796","article-title":"Intracerebroventricular oxytocin stimulates maternal behaviour in the sheep","volume":"46","author":"Kendrick","year":"1987","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neubiorev.2022.104870_bib67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1866-1955-5-7","article-title":"Social and emotional processing in Prader-Willi syndrome: genetic subtype differences","volume":"5","author":"Key","year":"2013","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neubiorev.2022.104870_bib68","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ajmg.1320320235","article-title":"Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion","volume":"32","author":"Knoll","year":"1989","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib69","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nature03701","article-title":"Oxytocin increases trust in humans","volume":"435","author":"Kosfeld","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104870_bib70","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.3390\/ijms22073613","article-title":"A comprehensive review of genetically engineered mouse models for prader-willi syndrome research","volume":"22","author":"Kummerfeld","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2022.104870_bib71","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/cen.13169","article-title":"Promising effects of oxytocin on social and food-related behaviour in young children with Prader\u2013Willi syndrome: a randomized, double-blind, controlled crossover trial","volume":"85","author":"Kuppens","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib72","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2148-13-238","article-title":"The vertebrate ancestral repertoire of visual opsins, transducin alpha subunits and oxytocin\/vasopressin receptors was established by duplication of their shared genomic region in the two rounds of early vertebrate genome duplications","volume":"13","author":"Lagman","year":"2013","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12413","article-title":"Measuring oxytocin and vasopressin: bioassays, immunoassays and random numbers","volume":"28","author":"Leng","year":"2016","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib74","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrn1845","article-title":"Dendritic peptide release and peptide-dependent behaviours","volume":"7","author":"Ludwig","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104870_bib75","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ajmg.1320350307","article-title":"Comparison of the 15q deletions in Prader-Willi and Angelman syndromes: specific regions, extent of deletions, parental origin, and clinical consequences","volume":"35","author":"Magenis","year":"1990","journal-title":"Am. J. Med. Genet"},{"key":"10.1016\/j.neubiorev.2022.104870_bib76","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0006-3223(98)00190-5","article-title":"Cerebrospinal fluid levels of oxytocin in Prader\u2013Willi syndrome: a preliminary report","volume":"44","author":"Martin","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104870_bib77","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM199206113262404","article-title":"The frequency of uniparental disomy in Prader-Willi syndrome. Implications for molecular diagnosis","volume":"326","author":"Mascari","year":"1992","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2022.104870_bib78","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.neubiorev.2013.04.018","article-title":"Problems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted?","volume":"37","author":"McCullough","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2022.104870_bib79","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.biopsych.2006.09.007","article-title":"Sensitivity to intranasal oxytocin in adult men with early parental separation","volume":"61","author":"Meinlschmidt","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104870_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004291","article-title":"Loss of magel2, a candidate gene for features of Prader-Willi syndrome, impairs reproductive function in mice","volume":"4","author":"Mercer","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104870_bib81","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn3044","article-title":"Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine","volume":"12","author":"Meyer-Lindenberg","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104870_bib82","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopsych.2014.11.010","article-title":"An early postnatal oxytocin treatment prevents social and learning deficits in adult mice deficient for Magel2, a gene involved in Prader-Willi syndrome and autism","volume":"78","author":"Meziane","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104870_bib83","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajmg.a.38160","article-title":"Oxytocin treatment in children with Prader\u2013Willi syndrome: a double-blind, placebo-controlled, crossover study","volume":"173","author":"Miller","year":"2017","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.neubiorev.2022.104870_bib84","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1093\/hmg\/9.20.3101","article-title":"Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader\u2013Willi syndrome","volume":"9","author":"Muscatelli","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib85","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/342281a0","article-title":"Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome","volume":"342","author":"Nicholls","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104870_bib86","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ajmg.1320330109","article-title":"Restriction fragment length polymorphisms within proximal 15q and their use in molecular cytogenetics and the Prader-Willi syndrome","volume":"33","author":"Nicholls","year":"1989","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib87","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0168-9525(98)01432-2","article-title":"Imprinting in Prader\u2013Willi and Angelman syndromes","volume":"14","author":"Nicholls","year":"1998","journal-title":"Trends Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib88","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ana.25314","article-title":"Cerebrospinal fluid vasopressin and symptom severity in children with autism","volume":"84","author":"Oztan","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib89","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.1073\/pnas.1919050117","article-title":"Neonatal CSF vasopressin concentration predicts later medical record diagnoses of autism spectrum disorder","volume":"117","author":"Oztan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104870_bib90","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1021\/bi047852m","article-title":"Neuropeptide processing profile in mice lacking prohormone convertase-1","volume":"44","author":"Pan","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.neubiorev.2022.104870_bib91","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/hbeh.2001.1655","article-title":"Central vasopressin administration regulates the onset of facultative paternal behavior in Microtus pennsylvanicus (meadow voles)","volume":"39","author":"Parker","year":"2001","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neubiorev.2022.104870_bib92","doi-asserted-by":"crossref","first-page":"8119","DOI":"10.1073\/pnas.1705521114","article-title":"Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism","volume":"114","author":"Parker","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104870_bib93","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam9100","article-title":"Arginine vasopressin in cerebrospinal fluid is a marker of sociality in nonhuman primates","volume":"10","author":"Parker","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neubiorev.2022.104870_bib94","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7356","article-title":"A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism","volume":"11","author":"Parker","year":"2019","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.neubiorev.2022.104870_bib95","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0150-15.2016","article-title":"Atypical social development in vasopressin-deficient brattleboro rats","volume":"3","author":"Paul","year":"2016","journal-title":"eNeuro"},{"key":"10.1016\/j.neubiorev.2022.104870_bib96","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1073\/pnas.76.12.6661","article-title":"Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin","volume":"76","author":"Pedersen","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2022.104870_bib97","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1601-183X.2005.00162.x","article-title":"Maternal behavior deficits in nulliparous oxytocin knockout mice","volume":"5","author":"Pedersen","year":"2006","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neubiorev.2022.104870_bib98","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neubiorev.2020.04.023","article-title":"Exogenous effects of oxytocin in five psychiatric disorders: a systematic review, meta-analyses and a personalized approach through the lens of the social salience hypothesis","volume":"114","author":"Peled-Avron","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2022.104870_bib99","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1172\/JCI91307","article-title":"Impaired prohormone processing: a grand unified theory for features of Prader-Willi syndrome? The","volume":"127","author":"Polex-Wolf","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neubiorev.2022.104870_bib100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0306-4522(89)90091-2","article-title":"Dendrites of hypothalamic magnocellular neurons release neurohypophysial peptides by exocytosis","volume":"32","author":"Pow","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104870_bib101","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1111\/bph.15481","article-title":"Oxytocin and vasopressin: signalling, behavioural modulation and potential therapeutic effects","volume":"179","author":"Rae","year":"2022","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.neubiorev.2022.104870_bib102","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1176\/appi.ajp.162.7.1361","article-title":"Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months","volume":"162","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104870_bib103","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.psyneuen.2011.07.013","article-title":"Effects of intranasal oxytocin and vasopressin on cooperative behavior and associated brain activity in men","volume":"37","author":"Rilling","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2022.104870_bib104","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1523\/JNEUROSCI.4260-08.2009","article-title":"Oxytocin makes a face in memory familiar","volume":"29","author":"Rimmele","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104870_bib105","first-page":"1219","article-title":"Molecular, cytogenetic, and clinical investigations of Prader-Willi syndrome patients","volume":"49","author":"Robinson","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib106","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000132749","article-title":"Regional mapping of the human gene encoding the novel pituitary polypeptide 7B2 to chromosome 15q13----q14 by in situ hybridization","volume":"50","author":"Roebroek","year":"1989","journal-title":"Cytogenet Cell Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib107","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/ng.158","article-title":"Prader-Willi phenotype caused by paternal deficiency for the HBII-85C\/D box small nucleolar RNA cluster","volume":"40","author":"Sahoo","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib108","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/ng.2776","article-title":"Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism","volume":"45","author":"Schaaf","year":"2013","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neubiorev.2022.104870_bib109","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1093\/hmg\/ddq424","article-title":"A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene","volume":"19","author":"Schaller","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s11689-021-09373-2","article-title":"Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium","volume":"13","author":"Schwartz","year":"2021","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neubiorev.2022.104870_bib111","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-61779-204-5_3","article-title":"The proprotein convertases, 20 years later","volume":"768","author":"Seidah","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib112","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJMoa2103583","article-title":"Intranasal oxytocin in children and adolescents with autism spectrum disorder","volume":"385","author":"Sikich","year":"2021","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2022.104870_bib113","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1093\/hmg\/ddp263","article-title":"A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism","volume":"18","author":"de Smith","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.neubiorev.2022.104870_bib114","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yfrne.2017.10.004","article-title":"Cross-talk among oxytocin and arginine-vasopressin receptors: relevance for basic and clinical studies of the brain and periphery","volume":"51","author":"Song","year":"2018","journal-title":"Front Neuroendocr."},{"key":"10.1016\/j.neubiorev.2022.104870_bib115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1210\/er.2015-1117","article-title":"PCSK1 mutations and human endocrinopathies: from obesity to gastrointestinal disorders","volume":"37","author":"Stijnen","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neubiorev.2022.104870_bib116","first-page":"573","article-title":"Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases","volume":"80","author":"Swaab","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neubiorev.2022.104870_bib117","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/PSY.0b013e31821df0c2","article-title":"Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin","volume":"73","author":"Szeto","year":"2011","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neubiorev.2022.104870_bib118","article-title":"Advances in human oxytocin measurement: challenges and proposed solutions","author":"Tabak","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104870_bib119","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1740774507081217","article-title":"An examination of the efficiency of the sequential parallel design in psychiatric clinical trials","volume":"4","author":"Tamura","year":"2007","journal-title":"Clin. Trials"},{"key":"10.1016\/j.neubiorev.2022.104870_bib120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/B978-0-12-820683-6.00026-9","article-title":"Prader-Willi syndrome: Hormone therapies","volume":"181","author":"Tauber","year":"2021","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib121","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S2213-8587(21)00002-4","article-title":"Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction","volume":"9","author":"Tauber","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib122","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1172-6-47","article-title":"Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients","volume":"6","author":"Tauber","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neubiorev.2022.104870_bib123","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2976","article-title":"The use of oxytocin to improve feeding and social skills in infants with Prader\u2013Willi syndrome","volume":"139","author":"Tauber","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.neubiorev.2022.104870_bib124","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.pharmtox.41.1.175","article-title":"The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists","volume":"41","author":"Thibonnier","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0306-4530(02)00133-6","article-title":"The effects of vasopressin on human facial responses related to social communication","volume":"29","author":"Thompson","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2022.104870_bib126","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/hmg\/8.8.1357","article-title":"Paternal deletion from snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to prader-willi syndrome","volume":"8","author":"Tsai","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib127","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddaa094","article-title":"Colocalization of Oxtr with Prader-Willi Syndrome transcripts in the trigeminal ganglion of neonatal mice","author":"Vaidyanathan","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib128","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00787-004-0354-6","article-title":"Prader-Willi syndrome--a study comparing deletion and uniparental disomy cases with reference to autism spectrum disorders","volume":"13","author":"Veltman","year":"2004","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104870_bib129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00041444-200512000-00006","article-title":"Autism spectrum disorders in Prader-Willi and Angelman syndromes: a systematic review","volume":"15","author":"Veltman","year":"2005","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib130","first-page":"427","article-title":"Dyssynchrony and perinatal psychopathology impact of child disease on parents-child interactions, the paradigm of Prader Willi syndrom","volume":"110","author":"Viaux-Savelon","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.neubiorev.2022.104870_bib131","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1073\/pnas.91.1.400","article-title":"Role of septal vasopressin innervation in paternal behavior in prairie voles (Microtus ochrogaster)","volume":"91","author":"Wang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2022.104870_bib132","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1749-6632.1992.tb34393.x","article-title":"Partner preference development in female prairie voles is facilitated by mating or the central infusion of oxytocin","volume":"652","author":"Williams","year":"1992","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.neubiorev.2022.104870_bib133","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/365545a0","article-title":"A role for central vasopressin in pair bonding in monogamous prairie voles","volume":"365","author":"Winslow","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104870_bib134","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0598-25","article-title":"A mouse model for Prader-Willi syndrome imprinting-centre mutations","volume":"19","author":"Yang","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neubiorev.2022.104870_bib135","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/23475","article-title":"Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole","volume":"400","author":"Young","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104870_bib136","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12264-016-0046-5","article-title":"Plasma oxytocin and arginine-vasopressin levels in children with autism spectrum disorder in china: associations with symptoms","volume":"32","author":"Zhang","year":"2016","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neubiorev.2022.104870_bib137","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.npep.2015.06.009","article-title":"Behavioural characteristics of the Prader\u2013Willi syndrome related biallelic Snord116 mouse model","volume":"53","author":"Zieba","year":"2015","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neubiorev.2022.104870_bib138","first-page":"91","article-title":"Vasopressinergic and oxytocinergic pathways in the central nervous system","volume":"43","author":"Zimmerman","year":"1984","journal-title":"Fed. Proc."},{"key":"10.1016\/j.neubiorev.2022.104870_bib139","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1352\/1944-7558-125.1.76","article-title":"Preliminary characterization of parent-child interaction in preschoolers with prader-willi syndrome: the relationship between engagement and parental stress","volume":"125","author":"Zyga","year":"2020","journal-title":"Am. J. Intellect. Dev. Disabil."},{"key":"10.1016\/j.neubiorev.2022.104870_bib140","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10803-014-2252-1","article-title":"Assessment of pretend play in Prader\u2013Willi syndrome: a direct comparison to autism spectrum disorder","volume":"45","author":"Zyga","year":"2015","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.neubiorev.2022.104870_fur1","unstructured":"AnonLevo Therapeutics Announces Top-line Results from Phase 3 CARE-PWS Study of LV-101 (Intranasal Carbetocin) for the Treatment of Prader-Willi Syndrome, 2020. Levo Therapeutics. URL \u3008https:\/\/www.levotx.com\/news\/care-pws_top-line_results\/\u3009 (accessed 5.16.22)."},{"key":"10.1016\/j.neubiorev.2022.104870_fur2","unstructured":"AnonLevo Therapeutics, Inc., 2021. Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS) (\u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03649477\u3009 Clinical trial registration No. NCT03649477). clinicaltrials.gov. (accessed 5.16.22)."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763422003591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763422003591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:18:06Z","timestamp":1758968286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763422003591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":142,"alternative-id":["S0149763422003591"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104870","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104870"}}